Day: March 14, 2025

StorageVault Announces Quarterly Dividend for Q1 2025

Written by Customer Service on March 14, 2025. Posted in Dividend Reports And Estimates.

TORONTO, March 14, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX) announced today that a quarterly dividend of $0.002946 per common share (“Common Share”) ‎will be payable on ‎April 15, 2025 to shareholders of record on March 31, 2025, with an ex-dividend ‎date of March 31, 2025. This dividend has been designated as an “eligible dividend” for Canadian ‎income tax ‎purposes.‎ ‎ About StorageVault Canada Inc.StorageVault currently owns and operates 251 storage locations across Canada. StorageVault owns ‎‎221 of these locations plus over 5,000 portable storage units representing over 12.6 million rentable ‎square feet on over 728 acres of land. StorageVault also provides last mile storage and logistics’ ‎solutions and professional records management services, ‎such as document and...

Plymouth Industrial REIT Declares Dividend for the First Quarter of 2025

Written by Customer Service on March 14, 2025. Posted in Dividend Reports And Estimates.

BOSTON, March 14, 2025 (GLOBE NEWSWIRE) — Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company”) today announced that its board of directors has declared a regular quarterly cash dividend of $0.24 per share of common stock for the first quarter of 2025. The dividend, which equates to an annualized rate of $0.96 per common share, is payable on April 30, 2025, to stockholders of record as of the close of business on March 31, 2025. About PlymouthPlymouth Industrial REIT, Inc. (NYSE: PLYM) is a full service, vertically integrated real estate investment company focused on the acquisition, ownership and management of single and multi-tenant industrial properties. Our mission is to provide tenants with cost effective space that is functional, flexible and safe. Contacts:Plymouth Industrial REIT, Inc.John WilfongSCR PartnersIR@p...

Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for First Quarter 2025

Written by Customer Service on March 14, 2025. Posted in Dividend Reports And Estimates.

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced that the Company’s board of directors has declared a cash dividend of $0.34 per share for the quarter ending March 31, 2025. The following are the key dates for the dividend:Record Date March 28, 2025Payment Date April 11, 2025The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of dividends on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, when the Company declares a cash dividend, stockholders who have not “opted out” of the DRIP in accordance with the terms of the DRIP and the procedures of their broker or other financial intermediary...

Ontario’s York Region Transit signs contract for 170 buses from NFI subsidiary New Flyer

Written by Customer Service on March 14, 2025. Posted in Public Companies.

WINNIPEG, Manitoba, March 14, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leading independent bus and coach manufacturer, subsidiary New Flyer Industries Canada ULC (New Flyer), today announced it has been awarded a significant contract with York Region Transit (YRT) for 170 Xcelsior® clean-diesel transit buses (268 equivalents units or EUs). This contract strengthens New Flyer’s position as a premier provider of sustainable mobility solutions and is part of NFI’s Q4 2024 backlog. The order includes 72 Xcelsior clean-diesel 40-foot buses (72 EUs) and 98 Xcelsior clean-diesel 60-foot buses (196 EUs). These state-of-the-art buses will be delivered over the next three years and, in combination with the agency’s previous 2023 purchase of 75 Xcelsior CHARGE NG® battery-electric buses, will enhance...

MRC Global Reports Full Year and Fourth Quarter 2024 Results

Written by Customer Service on March 14, 2025. Posted in Earnings Releases And Operating Results.

HOUSTON, March 14, 2025 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) today reported full year and fourth quarter 2024 results. Full Year 2024 Financial Highlights: ● Operating cash flows from continuing operations of $268 million, highest since 2015 ● Sales of $3,011 million ● Net income from continuing operations of $78 million ● Adjusted EBITDA of $202 million, 6.7% of sales ● Gross profit, as a percentage of sales, of 20.6% ● Adjusted Gross Profit, as a percentage of sales, of 21.9% and the third consecutive year above 21% ● Net Debt of $324 million, a 1.6x net debt leverage ratio Fourth Quarter 2024 Financial Highlights: ● Operating cash flows from continuing operations of $73 million ● Sales of $664 million ● Net loss from continuing operations of ($1) million ● Adjusted EBITDA of $32 million, or 4.8% of sales ● Gross profit,...

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Written by Customer Service on March 14, 2025. Posted in Public Companies.

– Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study –– Company expects to submit New Drug Application (NDA) in April 2025 – DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of desmopressin under development for the treatment of central diabetes insipidus. In a bioequivalence study conducted in 75 human subjects, ET-600 demonstrated pharmacokinetic equivalence to the U.S. Food and Drug Administration (FDA)-approved reference product of the same active ingredient. Healthy adults...

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Written by Customer Service on March 14, 2025. Posted in Public Companies.

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ILUVIEN in the U.S. under the combined label later this yearBAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). The approval also includes other updates to the label including to the Warnings and Precautions section. As previously announced, the Company plans to market ILUVIEN for chronic...

Dundee Precious Metals Announces Renewal of Normal Course Issuer Bid

Written by Customer Service on March 14, 2025. Posted in Public Companies.

TORONTO, March 14, 2025 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (the “Company”) announced today that the Toronto Stock Exchange (“TSX”) accepted its notice of intention to renew its normal course issuer bid (the “New Bid”) to purchase certain of its common shares (“Shares”) through the facilities of the TSX. The Company commenced a normal course issuer bid (the “Previous Bid”) on March 18, 2024, which will terminate on March 17, 2025. Under the Previous Bid, the Company sought and obtained approval to purchase up to 15.5 million Shares, representing approximately 9.8% of its public float as of March 6, 2024. As of February 28, 2025, the Company has repurchased 11,028,569 Shares under the Previous Bid through the TSX or other alternative trading systems or by such other means as permitted by the TSX and applicable...

AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

Written by Customer Service on March 14, 2025. Posted in Earnings Releases And Operating Results.

MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. “Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that delivers meaningful value for our shareholders,” stated Yogi Jashnani, Chief Executive Officer. “AirSculpt possesses many strengths given its proprietary method, its successful track record of providing more than 70,000 minimally invasive body contouring procedures and its international footprint with 32 centers in operation.” “While we anticipate facing a tough year-over-year comparison...

Pilgrim’s Announces $1.5 Billion Special Dividend and Long-term Capital Allocation Strategy

Written by Customer Service on March 14, 2025. Posted in Dividend Reports And Estimates.

Company Outlines Portfolio Enhancements, Brand Growth at Investor Day in New York GREELEY, Colo., March 14, 2025 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world’s leading food companies, today announced a capital deployment strategy in support of its ongoing efforts to improve its capital structure, enhance its diversified portfolio, stimulate brand growth and generate shareholder value. As a part of the strategy, the company’s board of directors has approved the declaration of a special cash dividend of $6.30 per share. The total amount of the special dividend payment will be approximately $1.5 billion, based on the current number of shares outstanding. The special cash dividend is payable on April 17, 2025, to stockholders of record on April 3, 2025. “Pilgrim’s is confident in the future of our...

Day: March 14, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals